RxDoctor Payments Data

Christopher Destephano, MD

Urogynecology and Reconstructive Pelvic Surgery · Jacksonville, FLNPI 1073812681

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $4,517 of the $6,640 with a category attached, or 68.0%. KARL Storz Endoscopy-america accounts for 93.8% of it on its own, with 4 other manufacturers making up the rest.

$6,640in general payments, 2019–2025

Across 7 payments — averaging $948.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • KARL Storz Endoscopy-america$6K
  • Hologic Sales And Service, LLC$133
  • Boston Scientific$108
  • Applied Medical Resources Corporation$85
  • Minerva Surgical, Inc$83
$50,783in research payments, 2019–2025

Across 7 payments — averaging $7254.71 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Hologic Sales And Service, LLC$28K
  • Hologic Inc$23K

What the payments were for

  • Grants$1,79927%
  • Travel & lodging$4,51768%
  • Food & beverage$3245%

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,640 in reported general payments places this provider in the 55th percentile of 81 urogynecology and reconstructive pelvic surgery providers in Florida.

See all urogynecology and reconstructive pelvic surgery providers in Florida

Medicare billing

Part B allowed, 2024
$20,966
Medicare patients
68
Services billed
143

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Estradiol28$3,669

Paid to pharmacies, not to this prescriber.

Other urogynecology and reconstructive pelvic surgery in Jacksonville

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →